[1] Kaplan JE, Benson C, Holmes KK, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(RR-4).
[2] Wang YF, Xu HF, Han ZG, et al. Serological surveillance for Penicillium marneffei infection in HIV-infected patients during 2004-2011 in Guangzhou, China. Clin Microbiol Infect. 2015;21(5):484–489. https://doi.org/10.1016/j.cmi.2014.12.014.
[3] Supparatpinyo K, Chiewchanvit S, Hirunsri P, et al. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Clin Infect Dis. 1992;14(4):871–874. https://doi.org/10.1093/clinids/14.4.871.
[4] Le T, Wolbers M, Chi NH, et al. Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam. Clin Infect Dis. 2011;52(7):945–952. https://doi.org/10.1093/cid/cir028.
[5] Larsson M, Nguyen LHT, Wertheim HF, et al. Clinical characteristics and outcome of Penicillium marneffei infection among HIV-infected patients in northern Vietnam. AIDS Res Ther. 2012;9(1):24. https://doi.org/10.1186/1742-6405-9-24.
[6] Hu Y, Zhang J, Li X, et al. Penicillium marneffei infection: an emerging disease in mainland China. Mycopathologia. 2013;175(1–2):57–67. https://doi.org/10.1007/s11046-012-9577-0.
[7] Qin Y, Huang X, Chen H, et al. Burden of Talaromyces marneffei infection in people living with HIV/AIDS in Asia during ART era: a systematic review and meta-analysis. BMC Infect Dis. 2020;20(1):551. https://doi.org/10.1186/s12879-020-05260-8.
[8] Ying RS, Le T, Cai WP, et al. Clinical epidemiology and outcome of HIV-associated talaromycosis in Guangdong, China, during 2011-2017. HIV Med. 2020;21(11):729–738. https://doi.org/10.1111/hiv.13024.
[9] Son VT, Khue PM, Strobel M. Penicilliosis and AIDS in Haiphong, Vietnam: evolution and predictive factors of death. Med Mal Infect. 2014;44(11–12):495–501. https://doi.org/10.1016/j.medmal.2014.09.008.
[10] Chastain DB, Henao-Martinez AF, Franco-Paredes C. Opportunistic invasive mycoses in AIDS: cryptococcosis, histoplasmosis, coccidiodomycosis, and talaromycosis. Curr Infect Dis Rep. 2017;19(10):36. https://doi.org/10.1007/s11908-017-0592-7.
[11] Zheng J, Gui X, Cao Q, et al. A clinical study of acquired immunodeficiency syndrome associated Penicillium marneffei infection from a non-endemic area in China. PloS One. 2015;10(6):e0130376. https://doi.org/10.1371/journal.pone.0130376.
[12] Vanittanakom N, Cooper CR Jr, Fisher MC, et al. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev. 2006;19(1):95–110. https://doi.org/10.1128/CMR.19.1.95-110.2006.
[13] Hien HTA, Thanh TT, Thu NTM, et al. Development and evaluation of a real-time polymerase chain reaction assay for the rapid detection of Talaromyces marneffei MP1 gene in human plasma. Mycoses. 2016;59(12):773–780. https://doi.org/10.1111/myc.12530.
[14] Pruksaphon K, Intaramat A, Ratanabanangkoon K, et al. Diagnostic laboratory immunology for talaromycosis (penicilliosis): review from the bench-top techniques to the point-of-care testing. Diagn Microbiol Infect Dis. 2020;96(3):114959. https://doi.org/10.1016/j.diagmicrobio.2019.114959.
[15] Wang YF, Cai JP, Wang YD, et al. Immunoassays based on Penicillium marneffei Mp1p derived from Pichia pastoris expression system for diagnosis of penicilliosis. PloS One. 2011;6(12):e28796. https://doi.org/10.1371/journal.pone.0028796.
[16] Thu NTM, Chan JFW, Ly VT, et al. Superiority of a novel Mp1p antigen detection enzyme immunoassay compared to standard BACTEC blood culture in the diagnosis of talaromycosis. Clin Infect Dis. 2021;73(2):e330-e336. https://doi.org/10.1093/cid/ciaa826.
[17] Prakit K, Nosanchuk JD, Pruksaphon K, et al. A novel inhibition ELISA for the detection and monitoring of Penicillium marneffei antigen in human serum. Eur J Clin Microbiol Infect Dis. 2016;35(4):647–656. https://doi.org/10.1007/s10096-016-2583-2.
[18] Pruksaphon K, Intaramat A, Ratanabanangkoon K, et al. Development and characterization of an immunochromatographic test for the early diagnosis of Talaromyces (Penicillium) marneffei. PloS One. 2018;13(4):e0195596. https://doi.org/10.1371/journal.pone.0195596.
[19] Ning C, Lai J, Wei W, et al. Accuracy of rapid diagnosis of Talaromyces marneffei: A systematic review and meta-analysis. PloS One. 2018;13(4):e0195569. https://doi.org/10.1371/journal.pone.0195569.
[20] Huang Y-T, Hung C-C, Liao C-H, et al. Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus. J Clin Microbiol. 2007;45(9):2858–2862. https://doi.org/10.1128/JCM.00050-07.
[21] Cao L, Chan CM, Lee C, et al. MP1 encodes an abundant and highly antigenic cell wall mannoprotein in the pathogenic fungus Penicillium marneffei. Infect Immun. 1998;66(3):966–973. https://doi.org/10.1128/IAI.66.3.966-973.1998.
[22] Woo PC, Lau SK, Lau CC, et al. Mp1p is a virulence factor in Talaromyces (Penicillium) marneffei. PLoS Negl Trop Dis. 2016;10(8):e0004907. https://doi.org/10.1371/journal.pntd.0004907.
[23] Cao L, Chan KM, Chen D, et al. Detection of cell wall mannoprotein Mp1p in culture supernatants of Penicillium marneffei and in sera of penicilliosis patients. J Clin Microbiol. 1999;37(4):981-6. https://doi.org/10.1128/JCM.37.4.981-986.1999.
[24] Ly VT, Thanh NT, Thu NTM, et al. Occult Talaromyces marneffei infection unveiled by the novel Mp1p antigen detection assay. Open Forum Infect Dis. 2020;7(11):ofaa502. https://doi.org/10.1093/ofid/ofaa502.
[25] Wang Y, Zeng L, Chen X, et al. [A double-antigen sandwich ELISA for detecting Penicillium marneffei Mp1p-specific antibody]. Nan Fang Yi Ke Da Xue Xue Bao. 2013;33(3):439-43.
[26] He K, Feng L, Liang Z, et al. Value of serum galactomannan test in diagnosis of AIDS complicated with penicilliosis marneffei. 2016;44(03):21-24.